Usefulness of Rimonabant (Acomplia) in reducing weight

Buy Acomplia and Compare prices of Rimonabant Here

USE OF RIMONABANT

Introduction

Rimonabant (Acomplia) a drug from the anorectic family is a popular life style medication increasingly being prescribed for control of obesity. It is the preferred prescription for patients whose bone mass index is greater than 30kgs/m or in excess of 27kgs/m in the case of patients who also suffer from type 2 diabetes. Many doctors also prefer Rimonabant (Acomplia) as an effective constituent of their smoking cessation and alcohol abuse therapy.

Usefulness of Rimonabant (Acomplia)

Control of Obesity.

Rimonabant (Acomplia) is from the cannabinoid family of drugs which is used to selectively block the receptors in the nervous system to contain ravenous appetites and modulate eating behavior. It does this by blocking the signals from the nervous system to the pituitary gland. This means that the endocrine system does not get the hunger and thirst signals. With the management of voracious appetites, the weight gradually reduces along with girth measurements and the obesity is brought within acceptable limits.

Smoking and Alcohol Abuse.
The craving for smoking and alcohol originates in the nervous system.Rimonabant (Acomplia) blocks the central mechanism in the brain that triggers the cravings for cigarettes and alcohol. This helps in cessation of these addictive habits.

Lipogenesis.
Rimonabant (Acomplia) is known to moderate the cardio metabolism of the patients and in doing so it streamlines their lipid profile. There is a marked increase in the good cholesterol HDL and a pronounced reduction in the bad cholesterol LDL levels.

Early Satiety.

The cannaabinoid receptors packed in just one 20 mg pill of Rimonabant (Acomplia) results in an early feeling of satiety. This is because the brain sends message that the appetite and thirst has been quenched and any more intake would result in uncomfortableness.

A last Word

This wonder drug which has the hearts of doctors and patients in forty countries of the world is about to enter the US markets rechristened as Zimulti.

This website is translated in English, Spanish, French, German and Italian